Posted: MAR 04, 2008

CSMG Technologies Announces Richard A. Auhll Joins Board Of Directors of Its Subsidiary Live Tissue Connect

Corpus Christi, TX, March 4, 2008 -- CSMG Technologies, Inc., (OTCBB: CTUM - News) a technology management company announced today that Richard A. Auhll has agreed to join the board of directors of its subsidiary, Live Tissue Connect ("LTC").

Mr. Don Robbins, President and CEO of CSMG Technologies, said, "We are delighted that Richard A. Auhll, former founder, Chairman, and president of Circon Corporation, a medical device company, has agreed to join the LTC board of directors. Richard has had an outstanding career in the medical device business. We continue to attract highly qualified medical device professionals to our company who have had already experienced great personal successes in the medical device field. We look forward to working with Richard as we enter the medical device markets and grow LTC."

LTC's Frank D'Amelio added, "Having worked with Richard for over 10 years at Circon, I found his advice and insight to be very valuable. I am confident that Richard will make meaningful contributions to LTC."

Richard A. Auhll added, "A strong and robust technology platform and a solid management team are two very key components to a company's success. Since I have known and worked with several key members of LTC's management team, I am excited to join LTC's Board and look forward to contributing to its success."

About Live Tissue Connect

LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC currently holds a total of approximately 44 patents and patent applications in the U.S., Australia, Canada, European Union, Ukraine and other countries.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to: www.csmgtechinternational.com/contact_information.html and fill-in information.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

CONTACT:

CSMG Technologies, Inc.
Donald S. Robbins, President and CEO
361-887-7546
or
K. Bruce Jones, 770-955-0409
or
ROI Group Associates, Inc.
Michael Dodge, 212-495-0744
mdodge@roiny.com